303 related articles for article (PubMed ID: 19210503)
1. Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study.
Kroft EB; Creemers MC; van den Hoogen FH; Boezeman JB; de Jong EM
Br J Dermatol; 2009 May; 160(5):1075-82. PubMed ID: 19210503
[TBL] [Abstract][Full Text] [Related]
2. Period of remission after treatment with UVA-1 in sclerodermic skin diseases.
Kroft EB; van de Kerkhof PC; Gerritsen MJ; de Jong EM
J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):839-44. PubMed ID: 18452527
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR
Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate infusion in low-risk gestational trophoblastic disease.
Wong LC; Ngan HY; Cheng DK; Ng TY
Am J Obstet Gynecol; 2000 Dec; 183(6):1579-82. PubMed ID: 11120531
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
[TBL] [Abstract][Full Text] [Related]
6. Long-term methotrexate for Crohn's disease: safety and efficacy in clinical practice.
Domènech E; Mañosa M; Navarro M; Masnou H; Garcia-Planella E; Zabana Y; Cabré E; Gassull MA
J Clin Gastroenterol; 2008 Apr; 42(4):395-9. PubMed ID: 18277899
[TBL] [Abstract][Full Text] [Related]
7. High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate.
Reinhold-Keller E; Fink CO; Herlyn K; Gross WL; De Groot K
Arthritis Rheum; 2002 Jun; 47(3):326-32. PubMed ID: 12115164
[TBL] [Abstract][Full Text] [Related]
8. Treatment of pediatric localized scleroderma with methotrexate.
Fitch PG; Rettig P; Burnham JM; Finkel TH; Yan AC; Akin E; Cron RQ
J Rheumatol; 2006 Mar; 33(3):609-14. PubMed ID: 16511930
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial.
Zulian F; Martini G; Vallongo C; Vittadello F; Falcini F; Patrizi A; Alessio M; La Torre F; Podda RA; Gerloni V; Cutrone M; Belloni-Fortina A; Paradisi M; Martino S; Perilongo G
Arthritis Rheum; 2011 Jul; 63(7):1998-2006. PubMed ID: 21305525
[TBL] [Abstract][Full Text] [Related]
10. Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease.
Fautrel B; Borget C; Rozenberg S; Meyer O; Le Loët X; Masson C; Koeger AC; Kahn MF; Bourgeois P
J Rheumatol; 1999 Feb; 26(2):373-8. PubMed ID: 9972972
[TBL] [Abstract][Full Text] [Related]
11. [Effects of primary chemotherapy with single methotrexate on low-risk gestational trophoblastic neoplasia and influencing factors thereof].
Chen YX; Shen YM; Qian JH; Xie X
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2109-12. PubMed ID: 16313819
[TBL] [Abstract][Full Text] [Related]
12. Brief Report: long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
Faurschou M; Westman K; Rasmussen N; de Groot K; Flossmann O; Höglund P; Jayne DR;
Arthritis Rheum; 2012 Oct; 64(10):3472-7. PubMed ID: 22614882
[TBL] [Abstract][Full Text] [Related]
13. A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea).
Zulian F; Vallongo C; Patrizi A; Belloni-Fortina A; Cutrone M; Alessio M; Martino S; Gerloni V; Vittadello F; Martini G
J Am Acad Dermatol; 2012 Dec; 67(6):1151-6. PubMed ID: 22657157
[TBL] [Abstract][Full Text] [Related]
14. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis.
Metzler C; Miehle N; Manger K; Iking-Konert C; de Groot K; Hellmich B; Gross WL; Reinhold-Keller E;
Rheumatology (Oxford); 2007 Jul; 46(7):1087-91. PubMed ID: 17519271
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients.
Wenzel J; Brähler S; Bauer R; Bieber T; Tüting T
Br J Dermatol; 2005 Jul; 153(1):157-62. PubMed ID: 16029342
[TBL] [Abstract][Full Text] [Related]
16. [Single methotrexate chemotherapy for low-risk gestational trophoblastic tumor].
Lu WG; Ding ZM; Xie X; Ye DF; Chen HZ; Feng SW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):414-7. PubMed ID: 12974085
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids.
Ramanan AV; Campbell-Webster N; Ota S; Parker S; Tran D; Tyrrell PN; Cameron B; Spiegel L; Schneider R; Laxer RM; Silverman ED; Feldman BM
Arthritis Rheum; 2005 Nov; 52(11):3570-8. PubMed ID: 16255046
[TBL] [Abstract][Full Text] [Related]
18. Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy.
Matsui H; Suzuka K; Yamazawa K; Tanaka N; Mitsuhashi A; Seki K; Sekiya S
Gynecol Oncol; 2005 Mar; 96(3):616-20. PubMed ID: 15721402
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children.
Weibel L; Sampaio MC; Visentin MT; Howell KJ; Woo P; Harper JI
Br J Dermatol; 2006 Nov; 155(5):1013-20. PubMed ID: 17034534
[TBL] [Abstract][Full Text] [Related]
20. [Cytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis].
Nakazaki S; Murayama T; Katoh S
Ryumachi; 2001 Dec; 41(6):929-37. PubMed ID: 11831013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
